Arthroamide, a Cyclic Depsipeptide with Quorum Sensing Inhibitory Activity from Arthrobacter sp

Area of Science:

• Microbiology
• Natural Products Chemistry
• Biochemistry

Background:

• Filamentous actinobacteria, like Streptomyces, are well-known for producing secondary metabolites.
• Nonfilamentous actinobacteria remain relatively underexplored for their potential in drug discovery.
• Actinobacteria isolated from unique environments like sandstone offer a promising source for novel bioactive compounds.

Purpose of the Study:

• To investigate the secondary metabolite production of nonfilamentous actinobacteria isolated from sandstone.
• To identify and characterize novel compounds with potential biological activities.
• To evaluate the quorum sensing inhibitory effects of isolated compounds on Staphylococcus aureus.

Main Methods:

• Isolation and cultivation of nonfilamentous actinobacteria from sandstone samples.
• Extraction and purification of secondary metabolites using chromatographic techniques.
• Structure elucidation of purified compounds using spectroscopic methods (e.g., NMR, MS).
• In vitro assays to assess quorum sensing inhibition of Staphylococcus aureus.

Main Results:

• An Arthrobacter strain was identified as a producer of secondary metabolites.
• A new cyclic peptide, arthroamide (1), was discovered and characterized.
• The known compound turnagainolide A (2) was co-isolated.
• Both arthroamide (1) and turnagainolide A (2) demonstrated significant inhibition of Staphylococcus aureus quorum sensing signaling at submicromolar to micromolar concentrations.

Conclusions:

• Nonfilamentous actinobacteria, specifically Arthrobacter species from sandstone, are a viable source of novel bioactive secondary metabolites.
• Arthroamide and turnagainolide A represent promising leads for developing new anti-virulence agents targeting bacterial communication.
• Further research into quorum sensing inhibitors could lead to novel strategies for combating antibiotic-resistant bacterial infections.